跳至主要内容
临床试验/NCT06243588
NCT06243588招募中不适用

Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma

Istituto Ortopedico Rizzoli1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2024年1月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
400
试验地点
1
主要终点
Correlation

研究概览

简要总结

assess whether there is a correlation between some factors (age, sex, tumor volume, tumor site, chemotherapy-induced necrosis, radiation and biomarkers) and overall survival (OS) and relapse-free survival (RFS) in patients with Ewing sarcoma.

Identification of reliable prognostic factors could help to identify high-risk patients, which may require a different treatment and follow up.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
2 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female patients treated at Rizzoli Orthopaedic Institute between 01/01/1991 and 31/12/2021
  • Age ≥ 2 years
  • Diagnosis of Ewing Sarcoma
  • Patients with available clinical and imaging data

排除标准

  • At least one inclusion criterion not met

结局指标

主要结局

Correlation

时间窗: At baseline (Day 0)

Correlation between some factors (age, sex, tumor volume, tumor site, chemotherapy-induced necrosis, radiation and biomarkers) and overall survival (OS) and relapse-free survival (RFS) in patients with Ewing sarcoma.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验